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Abstract: Identifying the associations between health and personality has been a focus for psychophysiological research. Type D personality is
associated with predisposition to physical and psychological ill-health. This statistician-blind parallel-group controlled trial (intervention group
vs. waiting list control group) examined the impact of Havening Techniques on the Type D constituents of negative affect (NA) and social
inhibition (SI). One hundred twenty-five adult (18+ years) participants in the United Kingdom (72 females, 53 males) completed the Type D
Scale-14 (DS14) measure of Type D personality at baseline (T1), 24-hours (T2), and at 1-month (T3). Forty participants in the treatment group
received additional stress biomarker assessment of heart rate, blood pressure, and salivary cortisol. Type D caseness remained stable in
the waiting list participants (n = 57). In the treatment group (n = 68); NA, SI, and total scores decreased from T1 to T2 (p < .001, p < .001, and
p < .001, respectively), and from T2 to T3 (p = .004, p < .001, and p < .001, respectively), significantly transmuting to non-caseness (p < .001 for
T1 to T2; p = .025 for T2 to T3). Between T1 and T2, decreases in cortisol (p < .001), diastolic blood pressure (p < .001), and systolic blood
pressure (p < .001) were demonstrated. Heart rate fell nonsignificantly between T1 and T2 (p = .063), but significantly from T1 to T3 (p = .048).
The findings of this study indicate the potential mutability of the psychophysiological illness-prone characteristics of Type D personality.
Keywords: Type D personality, cortisol, cardiovascular parameters, havening techniques, clinical trial
Type D personality is indicated by psychophysiological dis-
tress and characterized by the interaction between its neg-
ative affect (NA) and social inhibition (SI) constituents
(Denollet et al., 2006). This personality construct has been
associated with disease, somatic complaints (Jellesma,
2008), immunological vulnerability, health status, and the
development of psychiatric disorders (Williams et al.,
2008). In a systematic review, Mols and Denollet (2010)
concluded that Type D is a “vulnerability factor for general
psychological distress that affects mental and physical
health status and is associated with disease-promoting
mechanisms and work-related problems in apparently
healthy individuals” (p. 1). Type D personality manifests
in approximately 30% of the population (Horwood et al.,
2015), and given the longitudinal health impact of pro-
longed distress (Olive et al., 2016), the exploration of
targeted therapeutic interventions is a worthwhile area of
consideration in psychophysiological research to address
the adverse impact on health outcomes (Pedersen, Lemos,
et al., 2004).
Type D personality is grounded in the theoretical princi-
ple that the simultaneous presentation of NA and SI is a
determinant of psychophysiological distress, and a risk fac-
tor for a range of detrimental health consequences. Mols
and Denollet (2009) broadly define NA as “the tendency
to experience negative emotions” (p. 66). NA has a demon-
strable impact on neuroendocrine underpinnings of disease
and a wide variety of physiological concomitants (Herbert
& Cohen, 1993), alongside established links with coronary
heart disease (Frasure-Smith et al., 1995). Furthermore,
NA is correlated with maladaptive health behaviors,
reduced health-protective routines (Dalton & Hammen,
2018; Pedersen, Van Domburg, et al., 2004), and medica-
tion non-adherence (Molloy et al., 2012). The SI constituent
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of Type D is associated with a consistent tendency to “in-
hibit the expression of emotions and behaviors in social
interaction” (Denollet, 2000, p. 256). SI has been associ-
ated with a range of adverse health outcomes including
reduced heart rate variability (Carpeggiani et al., 2005),
increased inflammation (Maes et al., 1998), and reduced
treatment adherence (Pereira et al., 2004).
The adverse impact of Type D personality on outcomes
in patients with known cardiovascular disease has been
widely researched (Pedersen, Lemos, et al., 2004). In a
5–year follow-up of 541 patients with coronary heart dis-
ease, the combined NA and SI score (as a continuous mea-
sure) was associated with a significantly higher rate of the
combined end-point of cardiac death and acute myocardial
infarction after adjustment for age, sex, depressive symp-
toms, and disease severity (Denollet et al., 2013). This study
found a continuum of increased risk with combined NA and
SI scores, even among those who did not fulfill Type D
caseness cut-off. Importantly, participants with high NA
or SI scores alone were not at significantly increased risk.
Furthermore, Type D personality is associated with estab-
lished cardiovascular risk factors. Compare et al. (2014)
reported a significant association between Type D and
the presence of coronary artery atheromatous plaque
detected by computed tomography in 75 participants
without a history of coronary heart disease and this
remained significant after adjustment for conventional
cardiac risk factors as covariates. Hypertension increases
vulnerability to myocardial infarction, heart failure, and
stroke (Wilson et al., 1998). Therefore, the sustained eleva-
tion of blood pressure frequently observed in Type D
personality indicates a contributing risk of cardiovascular
disease (Denollet, 2005).
Previous psychophysiological research has identified dis-
tress-activated cortisol as a mediating physiological antago-
nist. Van Eck et al. (1996) found that negative affect is
related to elevated salivary cortisol secretion during normal
daily activities. Chronic distress also results in activation of
the sympathetic nervous system leading to hypertension,
tachycardia, and activation of the hypothalamic-pituitary-
adrenal axis, resulting in hypercortisolemia (Dickerson &
Kemeny, 2004). According to Conrad (2008), the adverse
psychophysiological consequences associated with chronic
distress predominantly result from cortisol-mediated neuro-
toxicity in the hippocampus. Accordingly, clinical psycho-
logical medicine studies identify elevations in heart rate,
blood pressure, and evidence of neuroendocrine stress
indices as robust physiological stress biomarkers in stress
testing methodology such as the “Trier Social Stress Test”
(Kirschbaum et al., 1993). Therefore, when examining the
literature in relation to Type D mechanisms, it is imperative
to consider the inextricable links with cortisol and blood
pressure to prevent “biological disturbances resulting from
chronic and uncontrollable stressors” (Herriot et al., 2018,
p. 850).
Denollet (2000) maintained that the Type D personality
construct is a risk factor for both cardiovascular disease
and mental ill health (including post-traumatic stress
responses). A number of studies have examined this link.
In an examination of the stress responses of N = 151 prison
staff, Kunst et al. (2009) found that Type D personality pre-
disposed individuals to the development of Post-Traumatic
Stress Disorder (PTSD). Cho and Kang (2017) found in
regression analysis that Type D personality significantly
predicted PTSD symptoms. In addition, the symptomatic
experience of post-trauma symptoms was demonstrated
to be more severe in firefighters with high Type D scores
(Orgińiska-Bulik & Langer, 2007). However, Rademaker
et al. (2011) in a prospective study of military personnel,
found no significant contribution of Type D personality to
the prediction of post-deployment trauma symptoms.
Although the links between Type D personality and trauma
symptoms have yet to be established, it is a developing area
of research interest.
Blair (2008) considered the intrinsic physiological func-
tional contributions of distress and asserted that the amyg-
dala is strongly implicated in stimulus-reinforcement
learning (particularly where there is maladaptive trauma
or distress-oriented cognitive and behavioral patterns).
Havening Techniques (HT) are an intervention intended
to affect amygdala-based distress cycles by using neuro-
chemical pathway reactivity to alter how responses to
trauma and distress are encoded (Ruden, 2011). HT is
based on the principle that sensory input can alter brain
function by re-establishing neurochemical resilience and
reducing chronic distress.
The HT sequencing pattern is comprised of three ele-
ments grounded in a theoretical understanding of neu-
rocognitive responses to distress: (1) brief activation of
emotional distress, (2) sensory input/distraction, and
(3) Havening touch. Extensive research into neurochemical
response to massage (Field et al., 2005) has demonstrated
the efficacy of touch in decreasing plasma cortisol while
raising dopamine and serotonin. Ruden (2018) has pro-
posed that the kinaesthetic component of HT augments
serotonin and consequently promotes gamma-aminobutyric
acid release, recognized to increase delta wave activity
(Ciranna, 2006; Darbari et al., 2005). This process is out-
lined in the model presenting the HT cortisol distress
reduction pathway in Figure 1. Van de Helm et al. (2011)
performed functional magnetic resonance imaging (fMRI)
and quantitative electroencephalographic (qEEG) studies
and found that delta waves during REM (rapid eye move-
ment) sleep depotentiates amygdala activity to neurochem-
ical and emotional reactivity. The researchers in this study
suggested that this mechanism of enabling psychological
Journal of Psychophysiology (2020) 2020 Hogrefe Publishing Distributed under the Hogrefe
OpenMind License (https://doi.org/10.1027/a000001)
2 K. L. Hodgson et al., A Psychophysiological Examination of Type D Personality
 
ht
tp
s:/
/e
co
nt
en
t.h
og
re
fe
.c
om
/d
oi
/p
df
/1
0.
10
27
/0
26
9-
88
03
/a
00
02
66
 - 
Tu
es
da
y,
 S
ep
te
m
be
r 2
9,
 2
02
0 
6:
08
:3
7 
A
M
 - 
IP
 A
dd
re
ss
:8
6.
15
9.
14
1.
16
4 
and physiological recovery is particularly relevant to the
REM and delta wave abnormalities associated with trau-
matic responses. Furthermore, this hippocampal shift to
the delta wave state was found to decrease cortisol levels
in a study by Van Cauter et al. (2000) which correlated
cortisol levels with polysomnographic recordings.
Multi-sensory metacognitive distractions are incorpo-
rated in HT in parallel with touch to enable the displace-
ment of distress-oriented cognition and disrupt negatively
encoded pathways (Ruden & Ruden, 2010). The theoretical
rationale for this constituent originates from research on
memory retrieval mechanisms, indicating that focusing on
a distressing memory in parallel with completing a distrac-
tion task creates competition for working memory retrieval
resources (Morey et al., 2009). Taxing the working memory
reduces the distress of the memory and acts as a barrier to
memory retrieval (Gunter & Bodner, 2008), this inhibits
outflow of the neurotransmitter glutamate in the basolateral
complex which contributes to emotional distress cycles
associated with repetitive memory retrieval (Ruden, 2011)
and cultivates neurochemical resilience. Gursimran et al.
(2015) assessed the efficacy of a single session HT interven-
tion in 27 health workers with a history of anxiety and/or
depression related occupational health impairment. Three
validated self-assessment questionnaires were employed
to assess anxiety, depression, and functional impairment.
HT significantly improved all scores at 1 week and further
significant improvements were reported 2 months post
intervention. The study reports encouraging results,
although its limitations included a small sample size and
the absence of a control group. However, the evaluation
of a treatment grounded in psychophysiological theory
offers an opportunity for further examination utilizing an
evidence-based framework.
This statistician-blind parallel-group controlled trial was
designed to test the hypothesis that HT administered to
participants presenting with Type D personality characteris-
tics at baseline (T1) was efficacious in decreasing Type D
Scale-14 (DS14) scores 24 hours post intervention (T2).
The secondary aims were to evaluate effects of HT on
biomarkers (heart rate, blood pressure, and salivary cortisol)
at T2 in a subgroup of participants, and to assess whether
early effects on DS14 scores and biomarkers were sustained
at T3 (one-month post-treatment).
Methods
Participants
Participants were recruited from existing self-referral
trauma resolution therapy caseloads of certified HT practi-
tioners in England following practitioner assessment for
Type D personality characteristics (based on the predefined
criteria established by Denollet, 2005). Following enrol-
ment, participants completed the DS14 questionnaire and
were included in this study irrespective of whether DS14
Type D caseness criteria were fulfilled (i.e., score cut-off
 10 for each domain), as continuum effects were observed
in previous research (Denollet et al., 2013), and taxometric
analysis research advises against categorical rigidity of the
DS14 measure (Ferguson et al., 2009). In addition, inclu-
sion criteria specified a sample of cognizant adults (age
18+ years), exclusion criteria for the biomarker evaluation
subgroup included a history of Hepatitis B, tuberculosis or
HIV due to clinical laboratory regulations.
The two-domain structure of the DS14 questionnaire
(Denollet, 2005), provides one score for NA and the second
for SI. Sample size calculations specified NA score to exam-
ine physiological effects (as advocated by Coyne & de
Voogd, 2012). Sample size calculations were based on a
study that investigated the impact of an 8-week self-referral
mindfulness-based stress reduction intervention on Type D
personality (Nyklicek, Beugen, & Denollet, 2013). The
reported effect size of the mindfulness-based stress reduc-
tion intervention on NA was 0.6. In order to perform sam-
ple size estimates, a similar mean baseline score of 16 and
SD = 5.2 was anticipated in this HT intervention trial. One
hundred six participants (> 53 in each group) are required to
identify a reduction in the score of 3 in the treatment versus
the waiting list group with 90% power and α = .05. There-
fore, this study necessitated the recruitment of a minimum
of 55 participants in the waiting list group and 55 in the
treatment group to ensure that the minimum sample size
calculations were achieved, allowing for a dropout of two
participants in each group.
Procedure
The research design employed a statistician-blind parallel
group comparison of HT treatment and waiting list groups.
The practitioners were selected because their practices rep-
resented varying waiting list timescales for treatment (half
Brief activation of distress to 
initiate neurochemical response 
from the amygdala
Distraction techniques using 
metacognitive multisensory
input
Application of Havening 
Touch to create delta wave
response (0.5-4.0Hz)
Stability of neurochemical recovery
SEROTONIN
CORTISOL
Figure 1. A model presenting the HT cortisol distress reduction
pathway.
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held a waiting list timescale for treatment engagement
greater than 2 months, the other half of less than a week),
enabling a natural group allocation process. An initial (non-
treatment) assessment was provided to determine the
appropriate support needs of each individual. The waiting
list group received their initial assessment, and were cog-
nizant of the waiting timescales from the outset Waiting list
participants subsequently received treatment following
their participation in this study. Informed consent was
obtained from all participants. In accordance with clinical
trial recommended guidelines, all participants continued
to see their health care providers while enrolled on this
trial.
The treatment group participants attended an appoint-
ment to receive a single session of HT administered by a
certified practitioner. The intervention comprised: the brief
activation of distress, HT touch applied to the face, arms
and palms, and specific distraction techniques. As this
research was designed to test the hypothesis that HT was
efficacious on the DS14 Type D measure of personality,
the DS14 questionnaire was utilized pre-treatment (T1),
24 hr post-treatment (T2), and 1 month later (T3). Partici-
pants accessed a Qualtrics questionnaire via either a PC
or smartphone in privacy to minimize practitioner bias;
the input was designed to take under 15 min. The waiting
list group completed the questionnaires at parallel time
points without receiving the intervention.
The biomarker evaluation subgroup of the treatment
group was assessed for blood pressure (BP), heart rate
(HR), and salivary cortisol in parallel with psychometric
testing at each timepoint to explore the influence of HT
on somatic pathophysiology. Collection of biomarkers was
undertaken by 11 practitioners who had a nursing or medi-
cal professional qualification, prior to completing the ques-
tionnaire in privacy.
Measures
To address the research aims, the use of the brief, psycho-
metrically sound and validated Type D Scale-14 (DS14)
measure of Type D personality (Denollet, 2005) was
identified as appropriate following extensive literature
review: The DS14 measure of Type D personality is a 14-
item psychometric questionnaire that utilizes a 5-point Lik-
ert scale, each item weighted from 0 to 4. The DS14 incor-
porates two 7-item subscales measuring the NA and SI
constituents of Type D. A score of  10 on both domains
confirms the presence of Type D caseness (i.e., meeting
the criteria for Type D). The DS14 demonstrates evidence
of internal consistency (α = .88/.86; N = 3,678), and test–
retest reliability (r = .72/.82) over a period of 3 months
(Denollet, 2005). Emons et al. (2007) used item response
theory to evaluate the psychometric properties of the
DS14 and found that in patients with cardiovascular disease
it is a valid measure. A secure online survey software
program (Qualtrics) was used to collect and collate data.
Embedded in this survey was a participant ID entry system,
information and informed consent form (tick box), a brief
demographic questionnaire (containing the sociodemo-
graphic variables of age and gender), the DS14 question-
naire, a blood pressure reporting system (for those in the
biomarker subgroup), and a debriefing section including a
referral link to further support.
Specific biomarker selection replicated earlier research
by Habra, Linden, Anderson, and Weinberg (2003) which
examined the relationship between Type D personality
and indices of cardiovascular health. At all three data time-
points; cardiovascular parameters and salivette samples
were taken following 30 min of rest in a sitting position.
Salivary cortisol levels were reported to be elevated in
Type D personality (Whitehead et al., 2007); contemporary
studies adopt a preference for salivary cortisol sampling
versus venepuncture methodology to eliminate the proce-
dural stress variable associated with blood tests (Dickerson
& Kemeny, 2004). Salivette samples were taken at identical
times of day (late morning to avoid circadian variation),
participants were instructed to avoid caffeine and eating
for at least 90 min prior to saliva sampling as this absten-
tion period is necessary because abrupt rises in cortisol
levels have been found in this period following food intake
(Toda et al., 2004). Samples were frozen (20 C) and
transferred to the laboratory on dry ice. To ensure anonym-
ity, the laboratory implemented a data barcode system
matched to participant IDs. Samples were held at the med-
ical laboratory and stored purely for the purposes of this
trial in accordance with the Human Tissues Act (Acts of
Parliament, 2004) research practice guidelines (paragraph
117–123). Clinical laboratory excellence guidelines and legis-
lation were adhered to. HR, systolic blood pressure (SBP),
and diastolic blood pressure (DBP) were measured (using
an Omron HEM-722C device, Omron Company, Kyoto,
Japan). A standard arm cuff was placed on the participant’s
non-dominant arm, and participants were advised to
remain still during cuff inflation for accurate measurement.
Blood pressure measurements were given in units of mil-
limeters of mercury (mmHg).
Data Analysis
Raw data for statistical analysis were recorded within the
Qualtrics database and subsequently analyzed using SPSS
for Windows version 23 (IBM Corporation, NY) by a
researcher blinded to treatment allocation (in order to min-
imize potential for research bias). The primary end-point
was change in DS14 score between T1 and T2, the
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secondary aims were to evaluate whether these effects per-
sisted one-month later (at T3), and the effect on psychobi-
ological variables. Prior to statistical analysis, a
Kolmogorov-Smirnov test was performed, and data were
normally distributed therefore parametric analyses were
conducted. Distributions of categorical variables were com-
pared using w2 tests. A mixed analysis of variance (ANOVA)
was undertaken to evaluate the interaction between time
and treatment allocation on psychometric scores. Where a
significant interaction was observed, unpaired t-tests were
performed to compare changes between groups in NA, SI,
and total DS14 scores between T1 and T2, T1 and T3,
and T2 and T3 in the treatment and waiting list group.
While the co-primary end points were the DS14 scores
and their constituents (NA and SI), analysis was also under-
taken for changes in Type D caseness (i.e., total DS14 score
of at least 10) in order to provide a context regarding the
clinical significance of the change in scores.
For analysis of the impact of HT on biomarker variables:
Salivary cortisol, systolic blood pressure (SBP), diastolic
blood pressure (DBP), heart rate (HR), and mean blood
pressure (MBP) calculated by (2  DBP + SBP)/3 were
compared at T1, T2, and T3. A one-way repeated-measures
analysis of variance (RM-ANOVA) was performed, with
Bonferroni correction, using time as the independent vari-
able and each physiological parameter as dependent vari-
ables. Where a significant interaction was observed, a
paired t-test was performed to compare these biomarkers
between T1 and T2, T1 and T3, and T2 and T3. The rela-
tionship between changes in DS14 score and changes in
biomarkers was assessed using Pearson’s correlation
coefficient.
Figure 2 presents a consort flow diagram detailing the
research phases and participant engagement in this paral-
lel-group controlled trial. The primary analysis was an
intention-to-treat approach where missing data were
imputed using the last-observation-carried-forward method
in accordance with standard practice for an intervention
trial. However, a per-protocol approach where data from
participants who withdrew and were excluded from initial
analysis is also presented in order to address the extent
to which the Type D personality construct is potentially
modifiable.
Results
Baseline Characteristics
A total of 68 and 57 participants were recruited into the
treatment and waiting list groups, respectively, although
3 (treatment) and 1 (waiting list) were lost to follow-up.
At treatment endpoint (T3) there were 125 participants
(56 waiting list, 25 psychometrics only treatment subgroup,
40 psychobiological, and psychometric evaluation treat-
ment subgroup). This was less than the anticipated dropout
rate of 5%, therefore sample size calculations were
exceeded across both groups. The distribution of men
and women in the treatment and waiting list groups was
well-matched (treatment group 42 of 68 vs. waiting list
30 of 57 female; w2 = 0.72, p = .397). Participants’ age data
were collected as a categorical variable representing
5 bands. Age distribution (%) did not differ significantly
between treatment and waitlist groups (w2 = 4.4, p = .351);
age band: 18–24 (5.9 vs. 15.8), 25–34 (13.2 vs. 7), 35–44
(29.4 vs. 24.6), 45–54 (20.6 vs. 19.3), 55 and over (30.9
vs. 33.8).
In the treatment group, 59 of 68 (87%) participants met
the DS14 criteria for type D caseness versus 54 of 57 (95%)
in the waiting list group (w2 = 3, p = .229). As shown in
Table 1, total DS14 scores did not differ significantly at
baseline (T1) between treatment and waiting list groups,
t(111) = 0.94, p = .348, Glass’s Δ = 0.13. NA and SI scores
were also similar at baseline between groups, t(108) = 1.25,
p = .215; and t(110) = 0.97, p = .334, Glass’s Δ = 0.14,
respectively. DS14 scores were comparable in the biomar-
ker and psychometric only treatment subgroups at baseline
(M = 40.3, SD = 11.9 and M = 41.4, SD = 11.3, respectively),
t(66) = 0.4, p = .691, Glass’s Δ = 0.09.
Efficacy of Havening Techniques on
Psychometric Questionnaire Scores and
Type D Caseness
As demonstrated in Figure 3 and Table 5 Type D caseness
remained stable across all three timepoints in the waiting
list participants (p = .887). In the treatment group, caseness
fell from T1 to T2 (w2 = 60, p < .001) and further from T2 to
T3 (w2 = 7.4, p = .025). Two non-Type D participants at
T1 met caseness at T2, and 44 who met Type D caseness
at T1 no longer met it at T2, and 7 who met caseness
at T2 no longer met it at T3, and 2 who did not meet it
at T2 met caseness at T3.
The results of the DS14 questionnaire in the treatment
and waiting list groups at T1, T2, and T3 are presented in
Table 1. While the DS14 data remained stable over time
in the waiting list participants, substantial decreases in both
NA and SI occurred post intervention. To assess whether
these changes were significant, a mixed ANOVA was
performed using time and treatment allocation as the inde-
pendent variables; highly significant time versus treatment
interactions were observed for NA, SI, and total DS14
scores (Table 2). As significant time-treatment interactions
were identified, post-hoc unpaired t-tests were per-
formed to compare changes in psychometric score data in
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treatment versus waiting list groups between T1 and T2, T1
and T3, and T2 and T3. The results are summarized in
Table 3. Effect sizes were calculated as Glass’s Δ to account
for different variances between the groups. Compared to
the waiting list group, the treatment group demonstrated
statistically significant reductions in NA and SI scores and
in total DS14 scores between T1 and T2, and further reduc-
tions between T2 and T3.
Assessment of eligibility (N = 131) and 
participant recruitment
Group Allocation (N = 125) 
determined by practitioner 
waiting times & capacity
Psychometric only group 
received treatment (n = 28)
Total excluded (n = 6).                  
Did not meet inclusion criteria (n = 4) 
Declined to participate (n = 2)
Assigned to waiting list 
group (n = 57)
(n = 68) Assigned to two 
treatment groups determined by 
practitioner BP training status
No treatment (n = 57)
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(T
3)
   
(T
2)
  
(T
1)
Biomarker subgroup received 
treatment (n = 40)
Lost to follow-up (n = 1)
No treatment (n = 57) Post treatment (n = 27)
Follow-up (n = 56) Follow-up (n = 25)
Lost to follow-up (n = 1) Lost to follow-up (n = 2)
Follow-up (n = 40)
Post treatment (n = 40)
Analysis at:                              
T2 on treatment (n = 40)
T3 on treatment (n = 40)
Analysis at:                              
T2 on treatment (n = 57)        
T2 intention to treat (n = 57)      
T3 on treatment (n = 56)             
T3 intention to treat (n = 57)
Analysis at:                              
T2 on treatment (n = 27)        
T2 intention to treat (n = 28)      
T3 on treatment (n = 25)             
T3 intention to treat (n = 28)
Treatment Group Analysis at:                
T2 on treatment (n = 67)                         
T2 intention to treat (n = 68)                  
T3 on treatment (n = 65)                         
T3 intention to treat (n = 68)
Figure 2. A CONSORT flow diagram of the research phases from enrolment to analysis. Group Allocation Descriptions: Waiting list: (participants
who remained on a waiting list until their completion in this study); Treatment Group (all participants receiving the treatment intervention);
biomarker subgroup (treatment group participants whose outcomes were assessed by psychometric and stress biomarker analysis);
Psychometric Only Subgroup (treatment group participants whose outcomes were assessed only by psychometric analysis).
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Efficacy of Havening Techniques in the
Biomarker Evaluation Subgroup
The demographic characteristics of the biomarker mea-
surement subgroup were comparable to those of the treat-
ment and waiting list groups: for biomarker subgroup
versus total treatment group, age: w2 = 3.1 (p = .54) and gen-
der: w2 = 0.48 (p = .55); and for biomarker subgroup versus
waiting list, age: w2 = 7.5 (p = .11) and gender: w2 = 0.053
(p = .839). Furthermore, baseline and post-intervention
DS14 scores in the biomarker subgroup were comparable
to those observed in the total treatment group (Table 1).
The evaluation analyses are per-protocol only, as no partic-
ipants in the subgroup were lost to follow-up. Figure 4 illus-
trates biomarker outcomes at T1, T2, and T3.
Reductions in biomarker parameters were evident fol-
lowing HT (Figure 4). SBP, in mmHg, decreased from T1
(M = 131.6, SD = 21.1) to T2 (M = 126.2, SD = 17.9), declining
further from T2 to T3 (M = 122.9, SD = 12.8). DBP, in
mmHg, reduced from T1 (M = 86.1, SD = 15.0) to T2
(M = 81.7, SD = 12.7), declining further from T2 to T3
(M = 80.1, SD = 10.7). MBP, in mmHg, also decreased from
T1 (M = 101.2, SD = 16.3) to T2 (M = 96.5, SD = 13.7), low-
ering further from T2 to T3 (M = 94.4, SD = 10.1). Heart
rate, in bpm, reduced from T1 (M = 74.6, SD = 11.9) to
T2 (M = 72.9, SD = 11.6), decreasing marginally from T2
to T3 (M = 72.2, SD = 11.1). Salivary cortisol, in ng/mL,
decreased from T1 (M = 5.3, SD = 3.5) to T2 (M = 4.2, SD
= 2.8), declining further from T2 to T3 (M = 3.7, SD =
3.3). To assess whether the differences were significant, a
one-way RM–ANOVA was performed on biomarkers with
time as the independent variable. Mauchly’s test indicated
that the assumption of sphericity was violated for these
biomarkers (p < .001 in all cases); therefore, the reported
p-values and degrees of freedom are adjusted using Green-
house-Geisser correction. Highly significant interactions
were found between time and systolic BP, diastolic BP,
mean BP, and cortisol: F(1, 1.5) = 16.7, p < .001; F(1, 1.3)
= 17.1, p < .001; F(1, 1.3) = 23.9, p < .001; and F(1, 1.5) =
40.1, p < .001, respectively. There was a modest interaction
between time and heart rate, F(1, 1.4) = 3.9, p = .024.
Table 1. Mean psychometric scores at T1, T2, and T3 in the treatment and waiting list groups
Analysis
Psychometric
scores
Time point
(T)
Treatment group
(n = 68) M (SD)
Waiting list group
(n = 57) M (SD)
Per-protocol NA T1 21.7 (5.5) 20.8 (2.8)
T2 9.2 (5.9) 21.0 (3.4)
T3 6.9 (5.6) 20.7 (3.0)
SI T1 19.3 (8.1) 18.2 (4.7)
T2 8.8 (3.6) 19.1 (4.4)
T3 7.1 (3.8) 20.3 (5.0)
Total DS14 T1 40.7 (11.5) 39.2 (6.7)
T2 18.0 (8.3) 40.2 (6.7)
T3 14.0 (8.1) 40.8 (6.6)
Intention-to-treat NA T1 21.7 (5.5) 20.8 (2.8)
T2 10.0 (6.3) 21.0 (3.4)
T3 7.9 (5.7) 20.3 (3.6)
SI T1 19.3 (8.1) 18.2 (4.7)
T2 9.6 (4.7) 19.1 (4.4)
T3 7.8 (4.6) 20.0 (5.3)
Total DS14 T1 40.7 (11.5) 39.2 (6.7)
T2 19.2 (9.8) 40.2 (6.7)
T3 15.0 (9.2) 40.1 (7.7)
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Figure 3. Percentage of participants meeting DS14 cut-off for Type D
caseness at T1, T2, and T3 in treatment and waiting list groups.
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Significant interactions were identified between time and
the biomarkers, therefore post hoc paired t-tests were
performed to assess changes between T1 and T2, T1 and
T3, and T2 and T3. As summarized in Table 4, significant
reductions in systolic, diastolic and mean blood pressures
were found between each time interval. Heart rate fell sig-
nificantly between T1 and T3 but there was no significant
difference between T1 and T2 and T2 and T3. Salivary cor-
tisol fell significantly between T1 and T2, and between T2
and T3.
The correlations between DS14 scores and biomarker
changes from T1 to T3 was assessed by Pearson’s correla-
tions as follows: SBP r(38) = .453, p = .003; for DBP r(38)
= .225, p = .163; for MBP r(38) = .371, p = .018; for HR
r(38) = .012, p = .94; and for cortisol r(38) = .237, p = .14.
Discussion
The results of this study confirmed the hypothesis that NA,
SI and composite DS14 scores would be reduced 24-hours-
post-HT. The effect sizes for these changes were substan-
tial, and considerably greater than the 0.6 effect size
assumed for the change in the primary end point for the
sample size calculation. Furthermore, Type D caseness fell
from 86.8% at T1 to 34.7% at T2 (24 hr post-treatment),
whereas, in the waiting list group, caseness was identical
at T1 and T2 (94.7%). The efficacy on DS14 scores was par-
alleled by beneficial effects on stress-related biomarkers
that are important in mediating cardiovascular disease risk,
with the biomarker evaluation treatment subgroup demon-
strating significant reductions in blood pressure and
Table 2. Mixed ANOVA on psychometric variables – time and treatment allocation as independent variables
Per-protocol analysis Intention-to-treat analysis
Psychometric
measures Variable F statistic df P
Psychometric
measures Variable F statistic df P
NA Time 144.0 2 < .001 Time 130.0 2 < .001
Treatment 107.0 1 < .001 NA Treatment 114.0 1 < .001
Time  Treatment 133.0 2 < .001 Time  Treatment 116.0 2 < .001
SI Time 52.9 2 < .001 Time 51.5 2 < .001
Treatment 99.1 1 < .001 SI Treatment 75.7 1 < .001
Time  Treatment 88.6 2 < .001 Time  Treatment 84.7 2 < .001
Total DS14 Time 121.0 2 < .001 Total DS14 Time 107.0 2 < .001
Treatment 213.0 1 < .001 Treatment 140.0 1 < .001
Time  Treatment 140.0 2 < .001 Time  Treatment 122.0 2 < .001
Note. Results are divided into per-protocol and intention-to-treat analyses.
Table 3. Change in psychometric scores in treatment and control groups between time points
Analysis Time points Measures
Treatment group
M (SD)
Waiting list group
M (SD) p
Glass’s Δ
effect size
Per-protocol T1 vs. T2 NA (DS14) 12.3 (7.4) 0.1 (3.0) < .001 4.0
SI (DS14) 10.0 (8.4) 0.6 (3.2) < .001 3.3
Combined DS14 22.2 (14.4) 0.5 (5.6) < .001 6.0
T1 vs. T3 NA (DS14) 15.0 (7.6) 0.4 (2.3) < .001 6.2
SI (DS14) 11.9 (8.8) 1.9 (3.5) < .001 3.9
Combined DS14 26.9 (14.9) 1.1 (4.2) < .001 4.8
T2 vs. T3 NA (DS14) 2.5 (4.4) 0.4 (2.3) .001 1.0
SI (DS14) 2.0 (3.9) 1.2 (3.9) < .001 1.1
Combined DS14 4.5 (7.2) 0.5 (4.6) < .001 1.4
Intention-to-treat T1 vs. T2 NA (DS14) 11.7 (7.5) 0.1 (3.0) < .001 3.8
SI (DS14) 9.8 (8.5) 0.6 (3.2) < .001 3.2
Combined DS14 21.5 (14.7) 0.5 (5.6) < .001 3.9
T1 vs. T3 NA (DS14) 13.9 (8.0) 0.4 (2.3) < .001 5.7
SI (DS14) 11.6 (8.9) 1.9 (3.5) < .001 3.8
Combined DS14 25.7 (15.6) 1.1 (4.2) < .001 6.3
T2 vs. T3 NA (DS14) 2.2 (4.2) 0.4 (2.3) .004 0.8
SI (DS14) 1.8 (3.8) 1.2 (3.9) < .001 0.8
Combined DS14 4.2 (7.1) 0.5 (4.6) < .001 1.0
Journal of Psychophysiology (2020) 2020 Hogrefe Publishing Distributed under the Hogrefe
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salivary cortisol, and modest reductions in heart rate. There
were further improvements in DS14 scores and in biomark-
ers between T2 (24 hr post-treatment) and T3 (one-month
follow-up). In contrast, no significant variation in scores was
observed in the waiting list group. There were moderate
significant correlations between changes in DS14 scores
between T1 and T3, and changes in SBP and MBP.
Type D caseness cut-off was met in 94.7% of the waiting
list group (M = 39.2) and 86.8% of the treatment group
(M = 40.7) at baseline, and most participants were mark-
edly above caseness threshold DS14 scores. The high scores
may be explained by the findings of Deane and Chamber-
lain (2007) who examined the predictors of help-seeking
and found that although only a small proportion of people
seek professional psychological support; increased distress
predicted a higher likelihood of treatment being sought.
Despite the stability of Type D in the absence of interven-
tion, significant beneficial effects of an 8-week mindfulness
intervention on DS14 scores have previously been demon-
strated (Nyklicek, Beugen, & Denollet, 2013), indicating
that it may be a personality construct amenable to interven-
tion. The results in the current HT intervention trial of
(A) (B)
(C) (D)
Figure 4. Line graphs of biomarker outcomes (mean scores including standard error bars). (A) Diastolic blood pressure; (B) Systolic Blood
Pressure; (C) Heart Rate; (D) Salivary Cortisol.
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significant improvement in scores reinforce the observa-
tions of Nyklicek, Beugen and Denollet (2013) and support
the theory that interventions may be efficacious in decreas-
ing illness propensity and transmuting expression of case-
ness in this population. The rapidity of effect of HT
observed 24 hr after a single intervention is a striking,
and perhaps surprising feature of our observations. These
results reinforce the challenge posed by the findings of
the mindfulness study to the stable personality trait
assumptions of Type D personality. Indeed, Roberts and
Mroczek (2008) presented evidence that personality trait-
change was responsive to life experiences in adulthood,
therefore interventions may present comparable causal
mechanisms for trait-change.
This study has several limitations. In this study, the effect
of HT on biomarker variables was assessed by repeated
measures ANOVA. While this is a standard statistical tech-
nique in studies such as this, the heterogeneity of time
points (i.e., 24 hr and 1 month) represents a potential limi-
tation, because correlation between data points tends to be
highest between adjacent time points. Further, treatment of
the participants by the same practitioners may have led to a
clustering effect. More detailed analyses in future studies
should use marginal or mixed models. Participants in this
study were “help-seeking” as they were recruited as a
self-referral waiting list cohort for a trauma-resolution
therapy. Wilson et al. (2005) asserted that there is a behav-
ior-change intention inherent in help-seeking, this was sup-
ported by Zartaloudi and Madianos (2010) who found that
people who underutilize self-referral services were less
likely to respond to intervention. The addition of a support-
ive therapist offers positive relational depth, this alone may
positively impact on the SI variable by “the capacity of
social support to buffer the negative effects of stress”
(Wiesmaierova et al., 2019, p. 1), indeed psychophysiologi-
cal benefits may also be observed as positive social experi-
ences are associated with lower mortality and improved
health (Berkman & Leonard Syme, 1979). A placebo or
best-available-therapy control group would address
whether this had any impact on stress biomarker or DS14
results and may yield valuable data that achieve double-
blinding as participants were cognizant of their specific
treatment allocation in this study.
Single point biomarker measures were explored in this
study under standardized conditions (identical times of
day, following 30 min of rest). The biomarker component
in this study was undertaken as a pilot. More detailed data
would be provided by the inclusion of ambulatory BP mea-
surement. There is inconsistency in the literature regarding
the cortisol awakening response in Type D. In survivors of
acute coronary syndrome, salivary cortisol was not
associated with severity, but cortisol awakening response
was positively (and independently) associated with Type
D personality (Whitehead et al., 2007). However, recently
Smith et al. (2018) demonstrated that there was no signifi-
cant relationship between basal cortisol levels and Type D
personality. Participants in this study were seeking treat-
ment for trauma resolution, and their salivary cortisol levels
were elevated compared to local reference values. Pacella
et al. (2014) found that treatment of PTSD in females,
but not males, was associated with normalization of the cor-
tisol awakening response. Accordingly, on balance, in a
definitive study cortisol awakening response may be supe-
rior to a single cortisol measurement. The results of this
trial indicate that participants’ stress biomarkers were
reduced following the HT intervention. However, stress
biomarkers were measured in resting state, and it would
be interesting to examine whether similar effects may be
replicated in an experimental stress protocol.
Table 4. Results from post hoc paired t-tests in the biomarker subgroup
Biomarkers T1 vs. T2 T1 vs. T3 T2 vs. T3
Systolic BP 131.6 vs. 126.2, p < .001 131.6 vs. 122.9, p < .001 126.2 vs. 122.9, p = .016
Glass’s Δ = .25 Glass’s Δ = .41 Glass’s Δ = .18
Diastolic BP 86.1 vs. 81.7, p < .001 86.1 vs. 80.1, p < .001 81.7 vs. 80.1, p = .048
Glass’s Δ = .29 Glass’s Δ = .35 Glass’s Δ = .07
Mean BP 101.2 vs. 96.5, p < .001 101.2 vs. 94.4, p < .001 96.5 vs. 94.4, p = .009
Glass’s Δ = .29 Glass’s Δ = .42 Glass’s Δ = .16
Heart rate 74.6 vs. 72.9, p = .063 74.6 vs. 72.2, p = .033 72.9 vs. 72.2, p = .253
Glass’s Δ = .14 Glass’s Δ = .2 Glass’s Δ = .06
Salivary cortisol 5.3 vs. 4.2, p < .001 5.3 vs. 3.7, p < .001 4.2 vs. 3.7, p = .003
Glass’s Δ = .33 Glass’s Δ = .48 Glass’s Δ = .19
Table 5. The effect of HT intervention on the proportion of participants
fulfilling Type D caseness criteria
Timepoint Treatment group Waiting list group
T1 n = 59 of 68 n = 54 of 57
T2 n = 16 of 67* n = 54 of 57
T3 n = 9 of 65+ n = 54 of 56
Note. *w2 = 60; p < .001 (T2 vs. T1 in treatment group); +w2 = 7.4; p = .025
(T3 vs. T2 in treatment group).
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As the selected measures demonstrated significant
improvements, future research recommendations include
the examination of a broader range of Type D and stress
measures to test the sensitivity of the DS14, the inclusion
of diagnostic analysis, and inclusion of a biomarker control
group in order to exclude the possible effect of time and
repeated assessment on biomarker improvement. More-
over, this clinical trial presents data demonstrating the
effect of HT on heart rate and BP, however, heart rate
variability (HRV) analysis provides valuable information
regarding baroreflex sensitivity, cardiac parasympathetic
and sympathetic tone. As SI has been associated with
reduced HRV (Carpeggiani et al., 2005), the use of HRV
analysis from electrocardiogram recordings may be useful
in future research.
Participants were recruited in this study following practi-
tioner assessment based on the predefined characteristics
of Type D personality established by Denollet (2005), a
small minority of the identified participants (5% of the wait-
ing list group and 13% of the treatment group) did not meet
the DS14 caseness cut-off for Type D personality. There-
fore, future research may consider DS14 criteria-based
recruitment methods exclusively. Furthermore, the addition
of a long-term follow-up period to assess sustained longitu-
dinal efficacy would be advantageous. Although this study
included a robust sample size with significant findings,
further research is recommended to ensure confident
generalizability.
Nevertheless, Type D personality is not a diagnosis, and
there are no associated clinical practice guidelines, despite
evidence that this construct is associated with impaired
well-being and is receptive to intervention (Mols &
Denollet, 2010). Pedersen, Lemos, et al. (2004) argued that
the extent to which Type D personality may respond to
treatment interventions needs to be examined to assess
the potential to decrease the risk of cardiovascular disease.
Therefore, the DS14 and stress biomarker measures may
have a role in the development and evaluation of evidence-
based health-protective interventions that consider the
impact on somatic pathophysiology in parallel with psycho-
logical well-being.
Historically, the primary focus of psychological medicine
research was the “demonstration that psychological influ-
ences could alter physiological processes in a way that
significantly contributed to pathogenesis” (Friedman &
Benson, 1994, p. 143) and that the clinical approach to
disease and health may be positively affected by psycholog-
ical intervention. Recent research by Ruden (2018) sub-
mits that HT endeavors to harness responses to stimuli
(particularly electroceutical delta waves) to enable psy-
chophysiological resilience through endogenous reparation.
However, these theoretically-grounded conclusions under-
pinning HT require further investigation in future research
using qEEG methodology. Nonetheless, hypothetically, the
stimulation of the brain’s intrinsic potential (by activating
intra-corporally) propounds an intervention with no known
side-effects. In conclusion, the marked effect of the inter-
vention on DS14 scores and on caseness, and the psychobi-
ological parameters associated with Type D personality
indicates the potential malleability of the personality con-
struct and indicates scope to further explore personality-
oriented health promotion and illness prevention interven-
tions from a psychophysiological perspective.
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